THE INFLUENCE OF TAURINE-CONTAINING MEDICINE «KRATAL» ON METABOLIC SYNDROME DEVELOPMENT INDUCED BY HIGH FAT DIET
DOI:
https://doi.org/10.21856/j-PEP.2013.2.11Keywords:
high fat diet, experimental metabolic syndrome, taurine, KratalAbstract
It has been established that taurine-containing preparation «Kratal» suppresses development
of insulin-resistance, glucose intolerance, abdominal obesity, hypertriglyceridemia, oxidative stress
and endothelial dysfunction. In male-rats with insulin-resistance induced by high fat diet finding
results have been based expediency of widening of spectrum of preparation «Kratal» application
for cardiovascular pathologies attenuation under metabolic syndrome conditions and type 2 diabetes
mellitus prophylaxis in persons from risk group.
References
Misra A, Misra A, Singhal N, Khurana L. J Amer Colledge Nutr 2010; 29(3):289S-301S.
Zachary T. Diabetes Care 2005; 28:2073-2080.
Kalupahana NS, Claycombe KJ, Moustaid-Moussa N. Adv Nutr 2011; 2:304-316.
Martins AR, Nachbar RT, Gorjao R, et al. Lipids Hlth Dis 2012; 11(30), available at: http://www.lipidworld.com /content/11/1/30.
Abebe W, Mozaffari MS. Amer J Cardiovasc Dis 2011; 1(3):293-311.
Song S, et al. Amer J Physiol Endocrinol Metabol 2001; 281(2):E275-282.
Arutyunyan AV, et al. Cankt-Peterburg, 2000:104 p.
Akinmokun A, Selby PL, Ramaiya K, Alberti KG. Diabet Med 1992; 9(4):432-437.
Sovremennye metody v biokhimii, pod red. Orekhovicha VN, Moskva, 1977:392 p.
Volchegorskiy IA, et al. Voprosy med. khimii 1989; 1:127-131.
Stal’naya ID,Garishvili GL. Sovremennye metody v biokhimii 1977:66-68.
Opredeleniya soderzhaniya vostanovlenogo glutationa v tkanyakh. Metody biokhimicheskikh issledovaniy (lipidnyy i energeneticheskiy obmen), pod red. M. I. Prokhorovoy, Leningrad, 1982:183-187.
Orlova EA. Ukr zhurn eksperim meditsiny 2002; 3(1):79-82.
Prokhorova MI, Tupikova ZN, Leningrad, 1965:218 p.
Men’shikov VV, Delektorskaya LN, Zolotnitskaya RP, pod red. Men’shikova VV, Moskva, 1987:365 p.
Fletcher MJ. Clin Acta 1969; 22(3):393-397.
Miller GL. Analyt Chem 1959; 31(5):964-966.
Glans S, Moskva,1998:459 p.
Misra A, Khurana l. J Clin Endocrinol Metab 2008; 93(11):S9-S30.
Poornima I, Parikh P, Shannon R. Circ Res 2006; 98:596-605.
Yang N, Ying C, Xu M, et al. Cardiovasc Res 2007; 76:167-174.
Pacher P, Beckman JS, Liaudet L. Physiol Rev 2007; 87:315-424.
Koh1 KK. Oh1 PC, Quon MJ. Cardiovasc Res 2009; 81:649-659.